Quest Diagnostics (DGX) has a market capitalization of $20.6B, based on 111.82M shares at a price of $184.07 (up 1% yesterday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
October 2025 | $184.07 | 8,182,400 | 111,823,448 | $20,583,342,073.36 |
September 2025 | $189.74 | 14,493,200 | 113,000,000 | $21,440,337,500.00 |
August 2025 | $180.84 | 17,557,100 | 113,000,000 | $20,434,581,000.00 |
July 2025 | $166.67 | 29,448,300 | 113,000,000 | $18,833,698,700.00 |
June 2025 | $178.03 | 16,264,600 | 113,000,000 | $20,117,073,600.00 |
May 2025 | $171.79 | 25,094,300 | 113,000,000 | $19,412,642,900.00 |
April 2025 | $176.63 | 35,004,500 | 113,000,000 | $19,959,167,400.00 |
March 2025 | $166.87 | 25,594,500 | 113,000,000 | $18,856,671,600.00 |
February 2025 | $170.52 | 20,149,600 | 113,000,000 | $19,269,019,900.00 |
January 2025 | $160.86 | 21,041,100 | 113,000,000 | $18,176,852,300.00 |
December 2024 | $148.06 | 16,152,700 | 113,000,000 | $16,730,881,700.00 |
November 2024 | $159.64 | 17,801,500 | 113,000,000 | $18,039,534,700.00 |
October 2024 | $151.96 | 17,965,400 | 113,000,000 | $17,171,163,600.00 |
September 2024 | $151.62 | 14,764,500 | 113,000,000 | $17,132,856,600.00 |
August 2024 | $153.30 | 15,897,000 | 113,000,000 | $17,322,674,000.00 |
July 2024 | $138.97 | 22,667,100 | 113,000,000 | $15,703,745,600.00 |
June 2024 | $132.96 | 13,998,800 | 112,000,000 | $14,891,979,200.00 |
May 2024 | $137.91 | 19,395,200 | 112,000,000 | $15,445,752,000.00 |
April 2024 | $134.23 | 25,310,100 | 112,000,000 | $15,033,412,800.00 |
March 2024 | $128.56 | 17,777,600 | 112,000,000 | $14,399,224,000.00 |
February 2024 | $120.63 | 23,193,800 | 112,000,000 | $13,510,022,400.00 |
January 2024 | $124.04 | 23,277,700 | 112,000,000 | $13,892,961,600.00 |
December 2023 | $132.47 | 17,241,600 | 113,000,000 | $14,969,426,400.00 |
November 2023 | $131.85 | 18,264,100 | 113,000,000 | $14,898,857,900.00 |
October 2023 | $125.00 | 23,235,700 | 113,000,000 | $14,124,762,700.00 |
